ロード中...
Comparison of Reported and Survey-Based Coverage in Onchocerciasis Programs over a Period of 8 Years in Cameroon and Uganda
Mass drug administration (MDA) with ivermectin must reach a high treatment coverage (90% of the eligible population) if onchocerciasis is to be eliminated. Questions have been raised as to whether reported treatment figures reaching such high coverage are reliable. Sample surveys are proposed as the...
保存先:
| 出版年: | Am J Trop Med Hyg |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The American Society of Tropical Medicine and Hygiene
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6493930/ https://ncbi.nlm.nih.gov/pubmed/30915956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.18-0680 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|